CDMO Insider Trading

Insider Ownership Percentage: 3.05%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $4,679,997.83

Avid Bioservices Insider Trading History Chart

This chart shows the insider buying and selling history at Avid Bioservices by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$4M-$2M$0$2M$4MTotal Insider BuyingTotal Insider Selling

Avid Bioservices Share Price & Price History

Current Price: $12.50
Price Change: Price Increase of +0.015 (0.12%)
As of 02/5/2025 05:23 PM ET

This chart shows the closing price history over time for CDMO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$12.49Closing price on 03/31/25:

SEC Filings (Institutional Ownership Changes) for Avid Bioservices (NASDAQ:CDMO)

97.16% of Avid Bioservices stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CDMO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$282Mbought$150MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M-$100M$0$100M$200MTotal InflowsTotal Outflows
Avid Bioservices logo
Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.
Read More on Avid Bioservices

Today's Range

Now: $12.50
Low: $12.47
High: $12.51

50 Day Range

MA: $12.49
Low: $12.42
High: $12.50

52 Week Range

Now: $12.50
Low: $6.14
High: $12.51

Volume

3,067,700 shs

Average Volume

1,313,767 shs

Market Capitalization

$799.18 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.39

Who are the company insiders with the largest holdings of Avid Bioservices?

Avid Bioservices' top insider shareholders include:
  1. Nicholas Stewart Green (CEO)
  2. Daniel R Hart (CFO)
  3. Joseph Carleone (Director)
  4. Richard B Hancock (Director)
  5. Mark R Ziebell (General Counsel)
  6. Richard A Richieri (Insider)
  7. Matthew R Kwietniak (Insider)
  8. Gregory Sargen (Director)
Learn More about top insider investors at Avid Bioservices.

Who are the major institutional investors of Avid Bioservices?

Avid Bioservices' top institutional investors include:
  1. Vanguard Group Inc. — 5.90%
  2. FIL Ltd — 4.00%
  3. Royal Bank of Canada — 3.92%
  4. Alpine Associates Management Inc. — 3.04%
  5. Nexpoint Asset Management L.P. — 2.90%
  6. Water Island Capital LLC — 2.50%
Learn More about top institutional investors of Avid Bioservices stock.

Which institutional investors are selling Avid Bioservices stock?

In the last quarter, CDMO stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Portolan Capital Management LLC
  3. Snyder Capital Management L P
  4. New York State Common Retirement Fund
  5. D. E. Shaw & Co. Inc.
  6. Marshall Wace LLP
  7. Invesco Ltd.
  8. Fisher Asset Management LLC
During the last year, company insiders that have sold Avid Bioservices company stock include:
  1. Nicholas Stewart Green (CEO)
  2. Daniel R Hart (CFO)
  3. Joseph Carleone (Director)
  4. Richard B Hancock (Director)
  5. Mark R Ziebell (General Counsel)
Learn More investors selling Avid Bioservices stock.

Which institutional investors are buying Avid Bioservices stock?

In the last quarter, CDMO stock was acquired by institutional investors including:
  1. FIL Ltd
  2. Alpine Associates Management Inc.
  3. Nexpoint Asset Management L.P.
  4. Water Island Capital LLC
  5. AQR Arbitrage LLC
  6. Hsbc Holdings PLC
  7. Jennison Associates LLC
  8. Alliancebernstein L.P.
Within the last year, these company insiders have bought Avid Bioservices stock:
  1. Nicholas Stewart Green (CEO)
  2. Daniel R Hart (CFO)
Learn More investors buying Avid Bioservices stock.